Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study.

about

Outcomes of patients with peripheral T-cell lymphoma in first complete remission: data from three tertiary Asian cancer centers.

P2860

Q47306867-905BB2B9-22BC-4D95-9791-60D6E5C6B9F6

P2860

Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study.

Item

http://www.wikidata.org/entity/Q48105111

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Outcome of peripheral T-cell l ...... wedish population-based study.

@en

Outcome of peripheral T-cell l ...... wedish population-based study.

@nl

type

Item

label

Outcome of peripheral T-cell l ...... wedish population-based study.

@en

Outcome of peripheral T-cell l ...... wedish population-based study.

@nl

prefLabel

Outcome of peripheral T-cell l ...... wedish population-based study.

@en

Outcome of peripheral T-cell l ...... wedish population-based study.

@nl

P1476

Outcome of peripheral T-cell l ...... wedish population-based study.

@en

P2093

Fredrik Ellin

http://www.w3.org/2001/XMLSchema#string

Lasse Hjort Jakobsen

http://www.w3.org/2001/XMLSchema#string

Mats Jerkeman

http://www.w3.org/2001/XMLSchema#string

Peter de Nully Brown

http://www.w3.org/2001/XMLSchema#string

Thomas Relander

http://www.w3.org/2001/XMLSchema#string

Thomas Stauffer Larsen

http://www.w3.org/2001/XMLSchema#string

P2860

Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.

Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer.

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors.

Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients.

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification.

P304

2815-2823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1300888

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Bøgsted

Tarec Christoffer El-Galaly

Henrik Cederleuf

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28317459

http://www.w3.org/2001/XMLSchema#string

P921

An t-Suain

Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study.

about

P2860

P2860

Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921